U.S. market Closed. Opens in 4 hours 27 minutes

SLRX | Salarius Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
RevenueN/AN/A1.84M5.23M3.47M838.00K1.27M1.01MN/A
Cost of Revenue10.05K6.68K19.18K6.91K4.02K431.00K507.00K663.00K49.88K
Gross Profit-10.05K-6.68K1.82M5.23M3.46M407.00K768.00K348.00K-49.88K
Operating Expenses12.89K22.98M14.65M12.84M11.73M22.48M35.49M40.23M29.21M
Selling, General & Admin5.72K7.14M6.10M6.11M7.71M10.57M18.50M19.86M16.46M
Research & Development7.17K15.84M8.55M6.91M4.02M11.91M16.99M20.38M12.75M
Other Operating ExpensesN/A8.87M-4.00-178.59KN/AN/AN/AN/AN/A
Operating Income-12.89K-31.84M-12.81M-7.79M-9.58M-22.07M-34.73M-39.89M-29.21M
Other Expenses / Income352.00233.18K44.69K434.09K1.33M152.01K291.96K393.11K72.00K
Before Tax Income-12.54K-31.61M-12.77M-7.35M-6.94M-21.92M-34.43M-39.49M-29.14M
Income Tax ExpensesN/A-233.18K-63.88K-255.50K-1.33M152.01K-324.58K-277.12K-49.85K
Net Income-12.54K-31.37M-12.70M-7.10M-5.61M-21.92M-34.43M-39.49M-29.14M
Interest ExpensesN/AN/AN/A3.05KN/AN/AN/AN/AN/A
Basic Shares Outstanding3.26M2.12M1.65M623.14K130.75K28.83K27.62K25.97K22.45K
Diluted Shares Outstanding3.26M2.12M1.65M623.14K130.75K28.83K27.62K25.97K22.45K
EBITDA-12.88K-31.60M-12.75M-7.33M-6.92M-22.07M-34.11M-39.89M-29.09M
EBITDA Margin0.00%0.00%-692.80%-140.09%-199.74%-2,634.16%-2,675.22%-3,945.23%0.00%
EBIT-12.54K-31.61M-12.77M-7.35M-6.94M-21.77M-34.76M-39.77M-29.19M
EBIT Margin0.00%0.00%-693.84%-140.43%-200.23%-2,597.85%-2,726.16%-3,933.74%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙